Product NDC: | 58394-004 |
Proprietary Name: | Neumega |
Non Proprietary Name: | oprelvekin |
Active Ingredient(s): | & nbsp; oprelvekin |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58394-004 |
Labeler Name: | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103694 |
Marketing Category: | BLA |
Start Marketing Date: | 19971101 |
Package NDC: | 58394-004-08 |
Package Description: | 10 CARTON in 1 TRAY (58394-004-08) > 1 KIT in 1 CARTON * 5 mL in 1 VIAL, SINGLE-DOSE (58394-104-08) * 1 mL in 1 SYRINGE (58394-019-02) |
NDC Code | 58394-004-08 |
Proprietary Name | Neumega |
Package Description | 10 CARTON in 1 TRAY (58394-004-08) > 1 KIT in 1 CARTON * 5 mL in 1 VIAL, SINGLE-DOSE (58394-104-08) * 1 mL in 1 SYRINGE (58394-019-02) |
Product NDC | 58394-004 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | oprelvekin |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 19971101 |
Marketing Category Name | BLA |
Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |